[HTML] mdpi.com

[HTML][HTML] Closing the door with CRISPR: genome editing of CCR5 and CXCR4 as a potential curative solution for HIV

JJ Freen-van Heeren - BioTech, 2022 - mdpi.com
Human immunodeficiency virus (HIV) infection can be controlled by anti-retroviral therapy.
Suppressing viral replication relies on life-long medication, but anti-retroviral therapy is not …
被引用次数：12 相关文章
[PDF] semanticscholar.org

[PDF][PDF] Closing the Door with CRISPR: Genome Editing of CCR5 and CXCR4 as a Potential Curative Solution for HIV. BioTech 2022, 11, 25

JJ Freen-van Heeren - 2022 - pdfs.semanticscholar.org
Human immunodeficiency virus (HIV) infection can be controlled by anti-retroviral therapy.
Suppressing viral replication relies on life-long medication, but anti-retroviral therapy is not …
[HTML] nih.gov

[HTML][HTML] Closing the Door with CRISPR: Genome Editing of CCR5 and CXCR4 as a Potential Curative Solution for HIV

JJ Freen-van Heeren - BioTech, 2022 - ncbi.nlm.nih.gov
Human immunodeficiency virus (HIV) infection can be controlled by anti-retroviral therapy.
Suppressing viral replication relies on life-long medication, but anti-retroviral therapy is not …

Closing the Door with CRISPR: Genome Editing of CCR5 and CXCR4 as a Potential Curative Solution for HIV

JJ Freen-van Heeren - BioTech, 2022 - search.proquest.com
Human immunodeficiency virus (HIV) infection can be controlled by anti-retroviral therapy.
Suppressing viral replication relies on life-long medication, but anti-retroviral therapy is not …

Closing the Door with CRISPR: Genome Editing of CCR5 and CXCR4 as a Potential Curative Solution for HIV.

JJ Freen-van Heeren - Biotech (Basel (Switzerland)), 2022 - europepmc.org
Human immunodeficiency virus (HIV) infection can be controlled by anti-retroviral therapy.
Suppressing viral replication relies on life-long medication, but anti-retroviral therapy is not …

Closing the Door with CRISPR: Genome Editing of CCR5 and CXCR4 as a Potential Curative Solution for HIV

JJ Freen-van Heeren - Biotech (Basel (Switzerland)), 2022 - pubmed.ncbi.nlm.nih.gov
Human immunodeficiency virus (HIV) infection can be controlled by anti-retroviral therapy.
Suppressing viral replication relies on life-long medication, but anti-retroviral therapy is not …

Closing the Door with CRISPR: Genome Editing of CCR5 and CXCR4 as a Potential Curative Solution for HIV.

JJ Freen-van Heeren - BioTech, 2022 - search.ebscohost.com
Human immunodeficiency virus (HIV) infection can be controlled by anti-retroviral therapy.
Suppressing viral replication relies on life-long medication, but anti-retroviral therapy is not …